Indication

Skin and skin structure Pseudomonas aeruginosa infection

A skin and skin structure *Pseudomonas aeruginosa* infection is an opportunistic bacterial infection of the cutaneous and underlying subcutaneous tissues caused by the Gram-negative pathogen *Pseudomonas aeruginosa*. Read more about Skin and skin structure Pseudomonas aeruginosa infection

142 drugs 79 manufacturers

Advertisement

Drugs that treat it

Common Skin and skin structure Pseudomonas aeruginosa infection therapies.

Showing 127–135 of 142 drugs

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
Avet Pharmaceuticals

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
AVET-NOVAPLUS

AZTREONAM

BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
Hospira

GENTAMICIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·SEPSIS CAUSED BY ENTEROBACTER·+63
Hikma Pharmaceuticals USA

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
FRESENIUS KABI
Filter & compare in the drug finder →Opens the drug finder with Skin and skin structure Pseudomonas aeruginosa infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Skin and skin structure Pseudomonas aeruginosa infection.

A skin and skin structure *Pseudomonas aeruginosa* infection is an opportunistic bacterial infection of the cutaneous and underlying subcutaneous tissues caused by the Gram-negative pathogen *Pseudomonas aeruginosa*.

The condition predominantly affects hospitalized, immunocompromised, or diabetic patients, as well as individuals with compromised epidermal integrity from severe burns, surgical incisions, trauma, or chronic ulcers.

Clinically and pathophysiologically, it can range from localized folliculitis to invasive, necrotizing tissue destruction and gangrenous lesions, such as ecthyma gangrenosum.

Virulence is driven by extracellular enzymes, exotoxins, and biofilm formation, often producing hallmark blue-green pyocyanin pigmentation, a sweet grape-like odor, and a substantial propensity for antimicrobial resistance.

Personalize your experience

Follow Skin and skin structure Pseudomonas aeruginosa infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it